カテゴリー： Grand View Research, 世界, 医療/バイオ

医薬品薬事申請（RA）のグローバル市場2023-2030：薬事コンサルティング、その他サービス

◆英語タイトル：Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By Category, By Service Provider, By Company Size, By Product Stage, By Indication, By Region, And Segment Forecasts, 2023 - 2030
	◆商品コード：GRV23SEP074 ◆発行会社（リサーチ会社）：Grand View Research ◆発行日：2023年8月 ◆ページ数：225 ◆レポート形式：英語 / PDF ◆納品方法：Eメール ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User	USD5,950 ⇒換算￥904,400	見積依頼/購入/質問フォーム
Multi User/Five User	USD6,950 ⇒換算￥1,056,400	見積依頼/購入/質問フォーム
Global/corporate License	USD8,950 ⇒換算￥1,360,400	見積依頼/購入/質問フォーム

★Grand View Researchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

医薬品薬事申請（RA）の市場成長と動向
Grand View Research, Inc.の最新レポートによると、世界の医薬品薬事申請（RA）の市場規模は2030年までに149億米ドルに達する見込みです。2023年から2030年までの年平均成長率は7.7%と予測されています。市場成長の主な要因は、規制環境の変化と、個別化医療、バイオシミラー、希少疾病用医薬品などの新興分野の成長です。FDAの医薬品承認プロセスには大きな変化がありました。最近、21世紀治療法案が可決され、特定の種類の医薬品に関するFDAの承認プロセスが迅速化される見込みです。

FDAは、重篤で生命を脅かす疾患に対する医薬品の審査を迅速化するために、4つのプログラム（Accelerated Approval、Priority Review、Fast Track、Breakthrough Therapy）を開始しました。これらのプログラムに基づく医薬品は、規制当局によってより早く承認されます。また、英国では、画期的な新薬への患者アクセスを迅速化するための政府主導の取り組みであるThe Accelerated Access Collaborativeが開始され、同国における新規治療薬の入手可能性とアクセシビリティの向上が期待されています。このような承認プロセスの変化により、技術革新が促進され、世界的な最近の承認プロセスの変化に精通した薬事サービスプロバイダーへの需要が高まると予想されます。

バイオシミラー、希少疾病用医薬品、個別化医薬品、コンパニオン診断薬、適応試験デザイン、その他の製品の市場の成長に伴い、これらの分野における薬事規制の専門性に対する需要は増加すると予想されます。企業が異業種に進出し、法規制遵守の負担の増大に直面するにつれ、薬事業務の専門知識を有するサービスプロバイダーに対する需要が高まっています。政府の資金援助により、特に先進国では希少疾病用医薬品の開発が大幅に加速しています。

複数の企業が市場での地位を獲得するため、提携、買収、新製品開発に取り組んでいます。例えば、フレイアは2022年10月、韓国の整形外科用インプラント製造会社と提携し、契約に基づき、薬事機器登録と法的代理人サービスを提供しました。さらに、2022年1月にはParexel International CorporationがRegulatory & Access Consulting Organizationを設立しました。この組織は、臨床試験の初期段階から薬事サポートを提供するために設立されました。

医薬品薬事申請（RA）市場レポートハイライト

- カテゴリー別では、医薬品分野が2022年に57%以上の最大収益シェアを獲得しました。人口増加、都市化の進展、質の高い医療に対する国内需要の高まりにより、革新的な医薬品を開発・製造する製薬企業に大きな可能性が生まれています。

- カテゴリー別では、マラリア、HIV/AIDS、非感染性疾患などの疾病の蔓延により、生物学的製剤分野が予測期間中に最速のCAGR 7.84%を記録すると予測されています。

- 適応症別では、免疫学分野が予測期間中に最速のCAGR 9.24%で成長すると予測されています。製薬・バイオ医薬品企業の強力な免疫学パイプラインが、同分野の成長をさらに押し上げると予測されます。

- 2022年の市場シェアは、がん領域が33.08%で最大でした。これは、がんの罹患率が高く、安全で効果的な治療オプションへのニーズが高まっているためと考えられます。

- 製品ステージ別では、臨床試験分野が2022年に46.41%の最大市場シェアを占めました。これは、臨床試験の登録件数が増加していることに起因しており、このセグメントの成長を牽引すると予想されます。

- 前臨床試験セグメントは、予測期間中にCAGR 8.40%で最速の成長が予測されています。癌、CVD、神経疾患などの既存疾患の有病率の増加が市場成長を促進する要因です。

- サービスプロバイダー別では、薬事業務のアウトソーシング分野が2022年に56.26%と最大の市場シェアを占め、予測期間中のCAGRは9.31%と最速になると予測されています。こうしたサービスの人気が高まっている背景には、アウトソーシングによって医療企業がコストを削減できることがあり、これが市場成長の主な要因となっています。

- 地域別では、アジア太平洋地域が2022年に市場を席巻し、37.46%の最大売上シェアを占めました。

第1章．調査手法＆範囲
第2章．エグゼクティブサマリー
第3章．医薬品薬事申請（RA）市場：市場変動・動向・範囲
第4章．医薬品薬事申請（RA）市場：サービス別分析、2018年〜2030年（百万米ドル）
第5章．医薬品薬事申請（RA）市場：カテゴリー別分析、2018年〜2030年（百万米ドル）
第6章．医薬品薬事申請（RA）市場：疾患別別分析、2018年〜2030年（百万米ドル）
第7章．医薬品薬事申請（RA）市場：製品ステージ別分析、2018年〜2030年（百万米ドル）
第8章．医薬品薬事申請（RA）市場：サービスプロバイダー別分析、2018年〜2030年（百万米ドル）
第9章．医薬品薬事申請（RA）市場：企業規模別分析、2018年〜2030年（百万米ドル）
第10章．医薬品薬事申請（RA）市場：地域別分析
第11章．医薬品薬事申請（RA）市場：競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.2 Estimates and Forecast Timeline
1.3 Market Definition
1.4 Research Methodology
1.5 Information Procurement
1.5.1 Information analysis
1.5.2 Market formulation & data visualization
1.5.3 Data validation & publishing
1.6 Research Scope and Assumptions
1.6.1 Commodity Flow Analysis
1.6.2 Top-down market estimation
1.6.3 Region/Country based segment share calculation
1.6.4 Multivariate analysis
1.6.5 Pharmaceutical regulatory affairs Market: CAGR Calculation
1.7 List of Secondary Sources
1.8 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Segment Snapshot
2.4 Segment Snapshot
2.5 Competitive Landscape Snapshot
Chapter 3 Pharmaceutical Regulatory Affairs Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Pharmaceutical Regulatory Affairs Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Changing regulatory landscape
3.2.1.2 Life sciences companies focusing on their core competencies
3.2.1.3 Economic and competitive pressures
3.2.1.4 Demand for the faster approval process for breakthrough drugs and devices
3.2.1.5 Entry of Companies into the global market
3.2.1.6 Growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs
3.2.2 Market Restraint Analysis
3.2.2.1 Risk associated with data security
3.2.2.2 Monitoring issues and lack of standardization
3.2.3 Industry Analysis – Porter’s
3.2.4 PESTEL Analysis
3.3 COVID- 19 Impact and Reformation Strategies
3.3.1 COVID-19 Impact On Clinical Trial Services Market
3.3.2 COVID-19 Impact on Regulatory Services Market
3.3.3 COVID-19 Impact on Key Market Players
3.3.3.1 medpace
3.3.3.2 Icon Plc
3.3.3.3 Labcorp
3.3.3.4 Charles River Laboratories
3.3.4 Post COVID-19 Market Scenario
3.4 Service Gap Analysis
3.4.1 Market Opportunities
3.4.1.1 Service Upgrade
3.4.1.2 Technological Advancements
3.4.1.3 Latest Trends
3.4.2 Market Challenges
3.4.2.1 Analysis Pertaining To Existing Gaps & Shortcomings In The Regulatory Services
3.4.2.2 Bottlenecks Faced By Companies Seeking Regulatory Approvals Or Maintaining Compliance
3.5 Africa’s Pharmaceutical Market Composition
3.5.1 Botswana
3.5.2 Namibia
3.5.3 Zimbabwe
3.5.4 Zambia
3.5.5 Tanzania
3.5.6 Rwanda
3.5.7 Ghana
3.5.8 Nigeria
3.5.9 Uganda
3.5.10 Mauritius
3.5.11 Kenya
3.6 Qualitative Analysis of Primary Factors Driving Market Demand for Pharmaceutical Products and Healthcare Services across the Aforementioned African Countries
3.6.1 Market Drivers Analysis
3.6.1.1 Population Growth
3.6.1.2 Increase Disease Burden
3.6.1.3 Rising Government Investments
3.6.2 Market Restraints Analysis
3.6.2.1 Weak Supply Chain Management
3.7 Best Practices and Case Studies Pertaining to Regulatory Affairs Services
Chapter 4 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Services, 2018 – 2030 (USD Million)
4.1 Pharmaceutical Regulatory Affairs Market: Services Movement Analysis
4.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Services (USD Million)
4.2.1 Regulatory Consulting
4.2.1.1 Legal Representation
4.2.1.2 Regulatory Writing & Publishing
4.2.1.3.1Writing
4.2.1.4.2Publishing
4.2.1.5 Product Registration & Clinical Trial Applications
4.2.2 Other Services
Chapter 5 Pharmaceutical Regulatory Affairs Market: Segment Analysis, By Category, 2018 – 2030 (USD Million)
5.1 Pharmaceutical Regulatory Affairs Market: Category Movement Analysis
5.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, By Category (USD Million)
5.2.1 Drugs
5.2.1.1 Innovator
5.2.1.1.1 Preclinical
5.2.1.1.2 Clinical
5.2.1.1.3Pre-Market Approval (PMA)
5.2.1.2 Generics
5.2.1.2.1 Preclinical
5.2.1.2.2 Clinical
5.2.1.2.3Pre-Market Approval (PMA)
5.2.2 Biologics
5.2.2.1 Biotech
5.2.2.1.1 Preclinical
5.2.2.1.2 Clinical
5.2.2.1.3 Pre-Market Approval (PMA)
5.2.2.2 ATMP
5.2.2.2.1 Preclinical
5.2.2.2.2 Clinical
5.2.2.2.3 Pre-Market Approval (PMA)
5.2.2.3 Biosimilars
5.2.2.3.1 Preclinical
5.2.2.3.2 Clinical
5.2.2.3.3 Pre-Market Approval (PMA)
Chapter 6 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Indication, 2018 – 2030 (USD Million)
6.1 Pharmaceutical Regulatory Affairs Market: Indication Movement Analysis
6.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Indication (USD Million)
6.2.1 Oncology
6.2.2 Neurology
6.2.3 Cardiology
6.2.4 Immunology
6.2.5 Others
Chapter 7 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Product Stage, 2018 – 2030 (USD Million)
7.1 Pharmaceutical Regulatory Affairs Market: Product Stage Movement Analysis
7.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Product Stage (USD Million)
7.2.1 Preclinical
7.2.2 Clinical studies
7.2.3 PMA
Chapter 8 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Service Provider, 2018 – 2030 (USD Million)
8.1 Pharmaceutical Regulatory Affairs Market: Service Provider Movement Analysis
8.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Service (USD Million)
8.2.1 In-house
8.2.2 Outsourcing
Chapter 9 Pharmaceutical Regulatory Affairs Market: Segment Analysis, by Company Size, 2018 – 2030 (USD Million)
9.1 Pharmaceutical Regulatory Affairs Market: Company Size Movement Analysis
9.2 Pharmaceutical Regulatory Affairs Market Estimates & Forecast, by Company Size (USD Million)
9.2.1 Small
9.2.2 Medium
9.2.3 Large
Chapter 10 Pharmaceutical Regulatory Affairs Market: Regional Analysis
10.1 Regulatory Affairs: Regional Market Share Analysis, 2022 & 2030
10.2 North America
10.2.1 North America pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.2.2 U.S.
10.2.2.1 Key country dynamics
10.2.2.2 Competitive scenario
10.2.2.3 Regulatory framework
10.2.2.4 U.S. pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.2.3 Canada
10.2.3.1 Key country dynamics
10.2.3.2 Competitive scenario
10.2.3.3 Regulatory framework
10.2.3.4 Canada pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3 Europe
10.3.1 Europe pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3.2 UK
10.3.2.1 Key country dynamics
10.3.2.2 Competitive scenario
10.3.2.3 Regulatory framework
10.3.2.4 Uk pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3.3 Germany
10.3.3.1 Key country dynamics
10.3.3.2 Competitive scenario
10.3.3.3 Regulatory framework
10.3.3.4 Germany pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.3.4 France
10.3.4.1 Key country dynamics
10.3.4.2 Competitive scenario
10.3.4.3 Regulatory framework
10.3.4.4 France pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3.5 Italy
10.3.5.1 Key country dynamics
10.3.5.2 Competitive scenario
10.3.5.3 Regulatory framework
10.3.5.4 ITALY pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3.6 Spain
10.3.6.1 Key country dynamics
10.3.6.2 Competitive scenario
10.3.6.3 Regulatory framework
10.3.6.4 SPAIN pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3.7 Russia
10.3.7.1 Key country dynamics
10.3.7.2 Competitive scenario
10.3.7.3 Regulatory framework
10.3.7.4 russia pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3.8 Turkey
10.3.8.1 Key country dynamics
10.3.8.2 Competitive scenario
10.3.8.3 Regulatory framework
10.3.8.4 Turkey pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3.9 Netherland
10.3.9.1 Key country dynamics
10.3.9.2 Competitive scenario
10.3.9.3 Regulatory framework
10.3.9.4 Netherland pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3.10 Switzerland
10.3.10.1 Key country dynamics
10.3.10.2 Competitive scenario
10.3.10.3 Switzerland pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.3.11 Sweden
10.3.11.1 Key country dynamics
10.3.11.2 Competitive scenario
10.3.11.3 Regulatory framework
10.3.11.4 Sweden pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.2 Japan
10.4.2.1 Key country dynamics
10.4.2.2 Competitive scenario
10.4.2.3 Regulatory framework
10.4.2.4 Japan pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.3 China
10.4.3.1 Key country dynamics
10.4.3.2 Competitive scenario
10.4.3.3 Regulatory framework
10.4.3.4 China pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.4 India
10.4.4.1 Key country dynamics
10.4.4.2 Competitive scenario
10.4.4.3 Regulatory framework
10.4.4.4 India pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.5 Australia
10.4.5.1 Key country dynamics
10.4.5.2 Competitive scenario
10.4.5.3 Regulatory framework
10.4.5.4 Australia pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.6 South Korea
10.4.6.1 Key country dynamics
10.4.6.2 Competitive scenario
10.4.6.3 Regulatory framework
10.4.6.4 South Korea pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.7 Indonesia
10.4.7.1 Key country dynamics
10.4.7.2 Competitive scenario
10.4.7.3 Regulatory framework
10.4.7.4 Indonesia pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.8 Malaysia
10.4.8.1 Key country dynamics
10.4.8.2 Competitive scenario
10.4.8.3 Regulatory framework
10.4.8.4 Malaysia pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.9 Thailand
10.4.9.1 Key country dynamics
10.4.9.2 Competitive scenario
10.4.9.3 Regulatory framework
10.4.9.4 Thailand pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.10 Singapore
10.4.10.1 Key country dynamics
10.4.10.2 Competitive scenario
10.4.10.3 Regulatory framework
10.4.10.4 Singapore pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.4.11 Taiwan
10.4.11.1 Key country dynamics
10.4.11.2 Competitive scenario
10.4.11.3 Regulatory framework
10.4.11.4 Taiwan pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.5 Latin America
10.5.1 Latin America pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.5.2 Brazil
10.5.2.1 Key country dynamics
10.5.2.2 Competitive scenario
10.5.2.3 Regulatory framework
10.5.2.4 Brazil pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.5.3 Mexico
10.5.3.1 Key country dynamics
10.5.3.2 Competitive scenario
10.5.3.3 Regulatory framework
10.5.3.4 Mexico pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.5.4 Argentina
10.5.4.1 Key country dynamics
10.5.4.2 Competitive scenario
10.5.4.3 Regulatory framework
10.5.4.4 Argentina pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.5.5 Colombia
10.5.5.1 Key country dynamics
10.5.5.2 Competitive scenario
10.5.5.3 Regulatory framework
10.5.5.4 Colombia pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.5.6 Chile
10.5.6.1 Key country dynamics
10.5.6.2 Competitive scenario
10.5.6.3 Regulatory framework
10.5.6.4 Chile pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.6 Middle East
10.6.1 Middle East pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.6.2 Saudi Arabia
10.6.2.1 Key country dynamics
10.6.2.2 Competitive scenario
10.6.2.3 Regulatory framework
10.6.2.4 Saudi Arabia pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.6.3 United Arab Emirates (UAE)
10.6.3.1 Key country dynamics
10.6.3.2 Competitive scenario
10.6.3.3 Regulatory framework
10.6.3.4 UAE pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.6.4 Egypt
10.6.4.1 Key country dynamics
10.6.4.2 Competitive scenario
10.6.4.3 Regulatory framework
10.6.4.4 Egypt pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.6.5 Israel
10.6.5.1 Key country dynamics
10.6.5.2 Competitive scenario
10.6.5.3 Regulatory framework
10.6.5.4 Israel pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.7 Africa
10.7.1 Africa pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.7.1.1 Competitive scenario
10.7.2 Botswana
10.7.2.1 Key country dynamics
10.7.2.2 Competitive scenario
10.7.2.3 Regulatory framework
10.7.2.4 Botswana pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.7.3 Namibia
10.7.3.1 Key country dynamics
10.7.3.2 Regulatory framework
10.7.3.3 Competitive scenario
10.7.3.4 Namibia pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.7.4 Zimbabwe
10.7.4.1 Key country dynamics
10.7.4.2 Key country dynamics
10.7.4.3 Competitive scenario
10.7.4.4 Regulatory framework
10.7.4.5 Zimbabwe pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.7.5 Zambia
10.7.5.1 Key country dynamics
10.7.5.2 Competitive scenario
10.7.5.3 Regulatory framework
10.7.5.4 pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.7.6 Tanzania
10.7.6.1 Key country dynamics
10.7.6.2 Competitive scenario
10.7.6.3 Regulatory framework
10.7.6.4 Tanzania pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.7.7 Rwanda
10.7.7.1 Key country dynamics
10.7.7.2 Competitive scenario
10.7.7.3 Regulatory framework
10.7.7.4 Rwanda pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.7.8 Ghana
10.7.8.1 Key country dynamics
10.7.8.2 Competitive scenario
10.7.8.3 Regulatory framework
10.7.8.4 Ghana pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.7.9 Nigeria
10.7.9.1 Key country dynamics
10.7.9.2 Competitive scenario
10.7.9.3 Regulatory framework
10.7.9.4 Nigeria pharmaceutical regulatory affairs market estimates and Forecasts, 2018 – 2030 (USD Million)
10.7.10 Uganda
10.7.10.1 Key country dynamics
10.7.10.2 Competitive scenario
10.7.10.3 Regulatory framework
10.7.10.4 Uganda pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.7.11 Mauritius
10.7.11.1 Key country dynamics
10.7.11.2 Competitive scenario
10.7.11.3 Regulatory framework
10.7.11.4 Mauritius pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
10.7.12 Kenya
10.7.12.1 Key country dynamics
10.7.12.2 Competitive scenario
10.7.12.3 Regulatory framework
10.7.12.4 Kenya pharmaceutical regulatory affairs market estimates and forecasts, 2018 – 2030 (USD Million)
Chapter 11 Pharmaceutical Regulatory Affairs Market: Competitive Landscape
11.1 Company Categorization
11.2 Participants’ Overview
11.3 Financial Performance
11.4 Service Benchmarking
11.4.1 Strategy Mapping
11.4.2 Acquisition
11.4.3 Expansion
11.4.4 Partnership
11.4.5 Others
11.4.6 Company Share Analysis
11.5 Additional list of 20 players operating in the Pharmaceutical Regulatory Affairs Market
11.5.1 SWOT Analysis
11.5.2 Heat Map Analysis
11.5.3 Service Benchmarking

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. List of Secondary Sources
Table 4. List of Abbreviations
Table 5. List of Secondary Sources
Table 6. List of Abbreviations
Table 7. Global Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 8. Global Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 9. Global Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 10. Global Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 11. Global Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 12. Global Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 13. Global Pharmaceutical Regulatory Affairs Market by Region, 2018 - 2030 (USD Million)
Table 14. North America Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 15. North America Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 16. North America Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 17. North America Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 18. North America Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 19. North America Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 20. North America Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 21. U.S. Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 22. U.S. Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 23. U.S. Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 24. U.S. Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 25. U.S. Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 26. U.S. Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 27. Canada Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 28. Canada Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 29. Canada Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 30. Canada Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 31. Canada Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 32. Canada Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 33. Europe Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 34. Europe Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 35. Europe Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 36. Europe Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 37. Europe Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 38. Europe Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 39. Europe Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 40. Germany Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 41. Germany Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 42. Germany Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 43. Germany Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 44. Germany Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 45. Germany Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 46. UK Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 47. UK Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 48. UK Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 49. UK Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 50. UK Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 51. UK Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 52. France Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 53. France Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 54. France Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 55. France Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 56. France Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 57. France Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 58. Italy Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 59. Italy Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 60. Italy Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 61. Italy Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 62. Italy Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 63. Italy Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 64. Spain Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 65. Spain Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 66. Spain Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 67. Spain Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 68. Spain Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 69. Spain Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 70. Russia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 71. Russia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 72. Russia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 73. Russia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 74. Russia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 75. Russia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 76. Turkey Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 77. Turkey Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 78. Turkey Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 79. Turkey Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 80. Turkey Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 81. Turkey Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 82. Netherlands Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 83. Netherlands Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 84. Netherlands Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 85. Netherlands Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 86. Netherlands Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 87. Netherlands Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 88. Switzerland Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 89. Switzerland Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 90. Switzerland Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 91. Switzerland Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 92. Switzerland Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 93. Switzerland Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 94. Sweden Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 95. Sweden Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 96. Sweden Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 97. Sweden Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 98. Sweden Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 99. Sweden Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 100. Asia Pacific Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 101. Asia Pacific Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 102. Asia Pacific Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 103. Asia Pacific Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 104. Asia Pacific Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 105. Asia Pacific Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 106. Asia Pacific Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 107. Asia Pacific Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 108. China Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 109. China Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 110. China Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 111. China Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 112. China Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 113. Japan Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 114. Japan Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 115. Japan Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 116. Japan Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 117. Japan Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 118. Japan Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 119. India Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 120. India Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 121. India Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 122. India Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 123. India Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 124. India Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 125. South Korea Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 126. South Korea Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 127. South Korea Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 128. South Korea Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 129. South Korea Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 130. South Korea Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 131. Australia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 132. Australia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 133. Australia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 134. Australia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 135. Australia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 136. Australia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 137. Thailand Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 138. Thailand Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 139. Thailand Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 140. Thailand Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 141. Thailand Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 142. Thailand Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 143. South Korea Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 144. South Korea Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 145. South Korea Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 146. South Korea Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 147. South Korea Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 148. South Korea Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 149. Indonesia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 150. Indonesia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 151. Indonesia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 152. Indonesia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 153. Indonesia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 154. Indonesia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 155. Malaysia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 156. Malaysia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 157. Malaysia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 158. Malaysia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 159. Malaysia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 160. Malaysia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 161. Singapore Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 162. Singapore Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 163. Singapore Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 164. Singapore Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 165. Singapore Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 166. Singapore Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 167. Taiwan Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 168. Taiwan Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 169. Taiwan Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 170. Taiwan Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 171. Taiwan Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 172. Taiwan Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 173. Latin America Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 174. Latin America Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 175. Latin America Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 176. Latin America Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 177. Latin America Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 178. Latin America Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 179. Latin America Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 180. Brazil Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 181. Brazil Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 182. Brazil Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 183. Brazil Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 184. Brazil Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 185. Brazil Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 186. Mexico Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 187. Mexico Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 188. Mexico Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 189. Mexico Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 190. Mexico Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 191. Mexico Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 192. Argentina Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 193. Argentina Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 194. Argentina Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 195. Argentina Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 196. Argentina Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 197. Argentina Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 198. Colombia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 199. Colombia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 200. Colombia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 201. Colombia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 202. Colombia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 203. Colombia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 204. Chile Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 205. Chile Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 206. Chile Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 207. Chile Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 208. Chile Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 209. Chile Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 210. Middle East Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 211. Middle East Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 212. Middle East Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 213. Middle East Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 214. Middle East Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 215. Middle East Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 216. Middle East Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 217. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 218. Saudi Arabia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 219. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 220. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 221. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 222. Saudi Arabia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 223. Egypt Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 224. Egypt Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 225. Egypt Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 226. Egypt Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 227. Egypt Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 228. Egypt Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 229. UAE Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 230. UAE Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 231. UAE Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 232. UAE Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 233. UAE Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 234. UAE Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 235. Israel Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 236. Israel Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 237. Israel Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 238. Israel Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 239. Israel Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 240. Israel Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 241. Africa Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 242. Africa Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 243. Africa Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 244. Africa Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 245. Africa Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 246. Africa Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 247. Africa Pharmaceutical Regulatory Affairs Market by Country, 2018 - 2030 (USD Million)
Table 248. Botswana Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 249. Botswana Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 250. Botswana Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 251. Botswana Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 252. Botswana Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 253. Botswana Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 254. Namibia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 255. Namibia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 256. Namibia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 257. Namibia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 258. Namibia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 259. Namibia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 260. Zimbabwe Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 261. Zimbabwe Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 262. Zimbabwe Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 263. Zimbabwe Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 264. Zimbabwe Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 265. Zimbabwe Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 266. Zambia Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 267. Zambia Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 268. Zambia Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 269. Zambia Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 270. Zambia Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 271. Zambia Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 272. Tanzania Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 273. Tanzania Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 274. Tanzania Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 275. Tanzania Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 276. Tanzania Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 277. Tanzania Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 278. Rwanda Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 279. Rwanda Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 280. Rwanda Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 281. Rwanda Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 282. Rwanda Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 283. Rwanda Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 284. Ghana Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 285. Ghana Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 286. Ghana Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 287. Ghana Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 288. Ghana Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 289. Ghana Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 290. Nigeria Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 291. Nigeria Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 292. Nigeria Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 293. Nigeria Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 294. Nigeria Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 295. Nigeria Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 296. Uganda Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 297. Uganda Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 298. Uganda Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 299. Uganda Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 300. Uganda Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 301. Uganda Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 302. Mauritius Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 303. Mauritius Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 304. Mauritius Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 305. Mauritius Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 306. Mauritius Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 307. Mauritius Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)
Table 308. Kenya Pharmaceutical Regulatory Affairs Market by Services, 2018 - 2030 (USD Million)
Table 309. Kenya Pharmaceutical Regulatory Affairs Market By Category, 2018 - 2030 (USD Million)
Table 310. Kenya Pharmaceutical Regulatory Affairs Market by Indication, 2018 - 2030 (USD Million)
Table 311. Kenya Pharmaceutical Regulatory Affairs Market by Product Stage, 2018 - 2030 (USD Million)
Table 312. Kenya Pharmaceutical Regulatory Affairs Market by Service Provider, 2018 - 2030 (USD Million)
Table 313. Kenya Pharmaceutical Regulatory Affairs Market by Company Size, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医薬品薬事申請（RA）のグローバル市場2023-2030：薬事コンサルティング、その他サービス(Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By Category, By Service Provider, By Company Size, By Product Stage, By Indication, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

医薬品薬事申請（RA）のグローバル市場2023-2030：薬事コンサルティング、その他サービス

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp